Navigation Links
Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
Date:9/17/2007

Trial Aims to Study Safety and Efficacy of Tengion's Neo-Bladder Construct

in Spinal Cord Injury Patients

EAST NORRITON, Pa., Sept. 17 /PRNewswire/ -- Tengion, Inc., a leader in regenerative medicine, announced today it has initiated a Phase 2 multi-center clinical trial of its neo-bladder construct, derived from a patient's own cells. The U.S.-based study is being conducted in 10 adult patients with neurogenic bladder due to spinal cord injuries. Neurogenic bladder is a condition that can occur due to spinal cord injury and may lead to kidney failure and incontinence, even when patients receive optimal medical treatment.

This Phase 2 trial initiation follows the successful completion of enrollment in the company's first (Phase 2) clinical trial of the autologous neo-bladder construct in pediatric patients with neurogenic bladder due to spina bifida. The commencement of Tengion's spina bifida Phase 2 clinical trial was announced in the first quarter of 2007.

"Tengion's novel regenerative medicine platform aims to address the significant limitations of current treatment options for patients with organ and tissue failure or loss," said Steven Nichtberger, M.D., President and CEO of Tengion. "Our neo-bladder constructs, which harness the body's natural ability to regenerate organs and tissues using a patient's own cells, hold the promise to meet critically important unmet medical needs. We look forward to announcing results from both of these Phase 2 clinical studies."

Similar to the Phase 2 study in pediatric patients, the new Phase 2 study in adult patients with spinal cord injuries is evaluating the safety and effectiveness of the neo-bladder construct at one year after implantation. The neo-bladder construct design is based on nearly two decades of research from Children's Hospital Boston (a teaching affiliate of Harvard Medical School), MIT, The Wake Forest Institute for Regenerative Medicine and Tengion. Previ
'/>"/>

SOURCE Tengion, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
2. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
3. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
4. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
5. NeurogesX Announces Presentation of Positive Phase 3 Clinical Data at the Second International Congress on Neuropathic Pain Meeting (NeuPSIG)
6. Repros Androxal Shows Highly Statistically Significant Positive Effects in Men with Secondary Hypogonadism
7. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
8. Positive Results for Second-Generation Taxus Liberte Coronary Stent System Highlighted in Journal of American College of Cardiology
9. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
10. Gilead Announces Achievement of Primary Efficacy Endpoint in Second Phase III Study of Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
11. Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)...CAGO, Nov. 29 FUJIFILM Medical Sys..., its revolutionary flat panel DR cassette, at the... Annual Meeting. Ideal for any clinical environme... provide clinicians with Fujifilm,s trademark imag...VO is a smart way for users to transition to DR wi...
(Date:11/28/2009)...HICAGO, Nov. 28 Siemens Healthcar...its Tim ® (Total imaging matrix) technology ...t) engine. Both technologies are introduced in the...new MAGNETOM Skyra* 3T scanners at the 95th Scient...al Society of North America (RSNA) from November 2...
(Date:11/26/2009)... JOHANNESBURG, South Africa, Nov. 26 /PRNewswire/ ...any of the Year Award in the Generic Pharmaceutica... Limited. ,, (Logo: http://www.newscom.com/cgi...of the Year Award, the following criteria were use...key competitors: growth strategy and implementatio...
Breaking Medicine Technology:FUJIFILM's DR Cassette Makes World Debut 2Siemens Introduces Its New Power Couple at RSNA 2009 2Siemens Introduces Its New Power Couple at RSNA 2009 3Siemens Introduces Its New Power Couple at RSNA 2009 4Siemens Introduces Its New Power Couple at RSNA 2009 5Siemens Introduces Its New Power Couple at RSNA 2009 6Siemens Introduces Its New Power Couple at RSNA 2009 7Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4Medication Compliance Is a Key Concern for Employers According to New Survey 61813 1Medication Compliance Is a Key Concern for Employers According to New Survey 61813 2Medication Compliance Is a Key Concern for Employers According to New Survey 61813 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex 28R 29 Fully Covered Esophageal Stent 6432 1Boston Scientific Announces FDA Clearance and CE Mark for WallFlex 28R 29 Fully Covered Esophageal Stent 6432 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex 28R 29 Fully Covered Esophageal Stent 6432 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex 28R 29 Fully Covered Esophageal Stent 6432 4Novel K anonymity algorithm safeguards access to data 61811 1
...livers remarkably shorter procedure ... Ablation Frontiers, Inc. today,announced that fo...8,Scientific Sessions reported positive early resu...that these findings aligned well with each,other a... The company,s innovative multi-electrode mapping ...
...aceuticals, a,division of Wyeth (NYSE: WYE ), ann...ation (FDA) issued an approvable letter on May 21 ...dulator, for the treatment of,postmenopausal osteo...ion,similar to that outlined in its approvable let...for the prevention of postmenopausal osteoporosis,...
Other Medicine Technology:Presentations From Recent Heart Rhythm Society Meeting Validate the Safety and Efficacy of Ablation Frontiers Technology in 230 Patients 2Presentations From Recent Heart Rhythm Society Meeting Validate the Safety and Efficacy of Ablation Frontiers Technology in 230 Patients 3Wyeth Receives Approvable Letter From FDA for Bazedoxifene for the Treatment of Postmenopausal Osteoporosis 2Wyeth Receives Approvable Letter From FDA for Bazedoxifene for the Treatment of Postmenopausal Osteoporosis 3
(Date:11/29/2009)...ogaForce A-Line Athletic Mat is great. It,s a ver...uthor and physician best known for establishing an... Go to www.yogaforce.com and order the new Mat t... San Francisco, CA (PRWEB) N... the YogaForce newly patented, revolutionary A-Lin...
(Date:11/28/2009)...swire/ -- Welcome to syngo® .plaza(1), ...tine from Siemens Healthcare. As the first P... from Siemens where 2D, 3D, and 4D reading come t...to change the way multimodality images are read to... 95th Scientific Assembly and Annual Meeting of th...
(Date:11/28/2009)...consider change after 30-minute psychosocial inter... (HealthDay News) -- A program that gets persisten...heir dangerous behavior may lead to significant an..., The new study included 184 men and women with t... were randomly assigned to one of two intervention...
(Date:11/28/2009)...ts, recognize signs of depression , , SA...rs, the holiday season can trigger melancholy as t...lth issues or worry about money problems, accordin... overcome the seasonal blues, the AGS Foundation f..., Get out and socialize or invite family and frien...
(Date:11/27/2009)...wswire/ - Uploadable USB pedometers may be new, bu... combination of advanced accelerometer functionali...rm concern over the accuracy of self-reported data... improved participation in a fitness program. ,...ness suppliers to integrate this technology. "Our ...
Breaking Medicine News(10 mins):Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 2Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 3Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 3Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:Seniors May Need Help Overcoming Holiday Blues 2Health News:New USB technology adds accountability and convenience to wellness programs 2
...pt. 3, 2008 Vietnamese Americans over 55, most wh... report more mental health problems than non-Hispa...alth Care Policy analysis of state data. , Vietna...ss likely to discuss such issues with their doctor...
...HHS Secretary Mike,Leavitt today welcomed 11 more ...ement to build a health care system where consumer...e value and quality of care., These communities w...ntly to improve care and make quality,and price in...
... In July, Christine Demers and Areeba Sadiq s... and the research coordinator at The Feinstein Ins...es but they were going West in search of the serum... set off for a family reunion in Arkansas. The nur...
...Sept. 3 Nobel Biocare announced,today it has reac...ainst,Keystone Dental, Inc., a dental implant comp...ity firm Warburg Pincus, in the Superior Court of,...ent Nobel Biocare employee through February 1, 200...
...s of the International Society for Cultural and Ac...versity of California, San Diego, Sept. 8-13, 2008...attend the conference with others participating fr...l dimensions of human practices where the context,...
...eptember 3, 2008): After receiving more than 1,500...ance of science and technology in this year,s elec...ners of its 2008 Election Multimedia Contest for C...t and Congress to create an energy independence in...
Other Medicine News:Health News:Older Vietnamese report more mental health problems 2Health News:HHS Designates 11 Communities Working to Improve Quality and Value of Health Care As Chartered Value Exchanges 2Health News:HHS Designates 11 Communities Working to Improve Quality and Value of Health Care As Chartered Value Exchanges 3Health News:Feinstein Institute: Researching a Family Tree of Autoimmune Disorders 2Health News:Feinstein Institute: Researching a Family Tree of Autoimmune Disorders 3Health News:Feinstein Institute: Researching a Family Tree of Autoimmune Disorders 4Health News:Feinstein Institute: Researching a Family Tree of Autoimmune Disorders 5Health News:Keystone Dental to Pay Nobel Biocare $2 Million to Settle Unfair Competition, Trade Secret Violations, and Tortious Interference Lawsuit 2Health News:ISCAR, world-wide conference on role of culture in human development, convenes at UCSD 2Health News:Young voters challenge presidential candidates to address science issues 2
CRP Full Range (0.1-160mg/l) Calibrator Series
CRP Calibrator (Multi-point, Liquid)
Fructosamine Controls Level 3
Drug Control Level 3
Medicine Products: